TUSC2
Basic information
Region (hg38): 3:50320027-50328251
Previous symbols: [ "PDAP2" ]
Links
Phenotypes
GenCC
Source: 
ClinVar
This is a list of variants' phenotypes submitted to 
- not_specified (14 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUSC2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000007275.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum | 
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 14 | 14 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 14 | 0 | 0 | 
GnomAD
Source: 
| Gene | Type | Bio Type | Transcript | Coding Exons | Length | 
|---|---|---|---|---|---|
| TUSC2 | protein_coding | protein_coding | ENST00000232496 | 3 | 8225 | 
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p | 
|---|---|---|---|---|---|---|
| 0.767 | 0.225 | 0 | 0 | 0 | 0 | 0.00 | 
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.07 | 35 | 57.9 | 0.605 | 0.00000323 | 683 | 
| Missense in Polyphen | 3 | 11.994 | 0.25013 | 151 | ||
| Synonymous | 1.30 | 15 | 22.9 | 0.654 | 0.00000135 | 226 | 
| Loss of Function | 2.04 | 0 | 4.82 | 0.00 | 2.92e-7 | 53 | 
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p | 
|---|---|---|
| African & African-American | 0.00 | 0.00 | 
| Ashkenazi Jewish | 0.00 | 0.00 | 
| East Asian | 0.00 | 0.00 | 
| Finnish | 0.00 | 0.00 | 
| European (Non-Finnish) | 0.00 | 0.00 | 
| Middle Eastern | 0.00 | 0.00 | 
| South Asian | 0.00 | 0.00 | 
| Other | 0.00 | 0.00 | 
dbNSFP
Source: 
- Function
- FUNCTION: May function as a tumor suppressor, inhibiting colony formation, causing G1 arrest and ultimately inducing apoptosis in homozygous 3p21.3 120-kb region-deficient cells.;
- Pathway
- miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase (Consensus) 
Recessive Scores
- pRec
- 0.0942
Haploinsufficiency Scores
- pHI
- 0.277
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Low | Low | Low | 
| Primary Immunodeficiency | Low | Low | Low | 
| Cancer | Low | Low | Low | 
Mouse Genome Informatics
- Gene name
- Tusc2
- Phenotype
- growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); neoplasm; immune system phenotype; renal/urinary system phenotype;
Gene ontology
- Biological process
- natural killer cell differentiation;phagocytosis;inflammatory response;cell cycle;cell-cell signaling;cell population proliferation;interleukin-15 production;negative regulation of interleukin-17 production;positive regulation of interleukin-10 production;cell maturation;regulation of mitochondrial membrane potential;response to defense-related host reactive oxygen species production;neutrophil mediated killing of gram-negative bacterium;chemokine (C-C motif) ligand 5 production;regulation of reactive oxygen species metabolic process
- Cellular component
- mitochondrion
- Molecular function
- protein binding